ATE462780T1 - Stabile, herg darstellende zellkulturen - Google Patents

Stabile, herg darstellende zellkulturen

Info

Publication number
ATE462780T1
ATE462780T1 AT06125765T AT06125765T ATE462780T1 AT E462780 T1 ATE462780 T1 AT E462780T1 AT 06125765 T AT06125765 T AT 06125765T AT 06125765 T AT06125765 T AT 06125765T AT E462780 T1 ATE462780 T1 AT E462780T1
Authority
AT
Austria
Prior art keywords
stable
herg
cell cultures
representing cell
representing
Prior art date
Application number
AT06125765T
Other languages
English (en)
Inventor
Paul Shartzer Dietrich
Ulrich Andreas Gubler
Heather Guthrie
Bruce Koch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE462780T1 publication Critical patent/ATE462780T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Golf Clubs (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06125765T 2005-12-21 2006-12-11 Stabile, herg darstellende zellkulturen ATE462780T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75301505P 2005-12-21 2005-12-21
US84196506P 2006-09-01 2006-09-01

Publications (1)

Publication Number Publication Date
ATE462780T1 true ATE462780T1 (de) 2010-04-15

Family

ID=37891741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06125765T ATE462780T1 (de) 2005-12-21 2006-12-11 Stabile, herg darstellende zellkulturen

Country Status (9)

Country Link
US (2) US7776590B2 (de)
EP (1) EP1801200B1 (de)
JP (1) JP4464954B2 (de)
CN (1) CN100516205C (de)
AT (1) ATE462780T1 (de)
CA (1) CA2571339C (de)
DE (1) DE602006013258D1 (de)
ES (1) ES2340604T3 (de)
SG (1) SG133563A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101498723A (zh) * 2009-02-27 2009-08-05 深圳先进技术研究院 离子通道药物筛选装置及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1423700A2 (de) 2001-09-04 2004-06-02 Pfizer Limited Affinitätsassay für den humanen erg kaliumkanal
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
US7510874B2 (en) 2003-10-28 2009-03-31 Wisconsin Alumni Research Foundation Stable cell lines expressing HERG1a and HERG1b
US7935526B2 (en) * 2003-11-17 2011-05-03 Eisai R & D Management Co., Ltd. hERG channel-expressing cell

Also Published As

Publication number Publication date
EP1801200A1 (de) 2007-06-27
JP4464954B2 (ja) 2010-05-19
CA2571339A1 (en) 2007-06-21
US20070141554A1 (en) 2007-06-21
US7776590B2 (en) 2010-08-17
CA2571339C (en) 2010-05-04
EP1801200B1 (de) 2010-03-31
CN1986783A (zh) 2007-06-27
JP2007167068A (ja) 2007-07-05
SG133563A1 (en) 2007-07-30
ES2340604T3 (es) 2010-06-07
US20100261191A1 (en) 2010-10-14
DE602006013258D1 (de) 2010-05-12
CN100516205C (zh) 2009-07-22
US8349572B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
CL2009001263S1 (es) Maquina de afeitar.
CL2007002182S1 (es) Terminal.
MX2009013706A (es) Celulas multipotentes/pluripotentes y metodos relacionados.
EP2265963A4 (de) Power-management-verbindungseinrichtungen und diesbezügliche verfahren
CL2009001380S1 (es) Mango de maquina de afeitar.
MX346001B (es) Polipeptidos de eritropoyetina animal modificados y sus usos.
GB2472731A (en) A self managed intelligent learning system
UY4151Q (es) Vincha con auriculares
CR9930A (es) Compuestos
BR112013033139A2 (pt) métodos e equipamentos para aprimorar os mecanismos de atualização de parâmetros de nfc
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
MX2010002028A (es) Metodos y composiciones para modular celulas t.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
EA201270381A1 (ru) Планшетная система с глубокими лунками и крышкой
EA201171332A1 (ru) Композиция для стерилизации поверхностей
CL2009001363S1 (es) Pieza para maquina de afeitar.
UY34360A (es) ?compuestos de tipo bisamida con actividad insecticida, procesos e intermediarios?
WO2006006080A3 (en) Sodium channel agonist
ATE462780T1 (de) Stabile, herg darstellende zellkulturen
ATE492133T1 (de) Dynamische bereitstellung einer dienstqualität für einen mobilen knoten
ATE556446T1 (de) Batterieanoden
EA201001442A1 (ru) Способ получения гидропероксидов алкилбензолов в мягких условиях и в присутствии новых каталитических систем
WO2009004664A3 (en) Immortalized cell line of murine mesenchymal stem cells, method for preparation and uses thereof
RS53014B (en) 4R, 5S-ENANTIOMER 2- (5-METHYL-2-OXO-4-PHENYL-PYROLIDIN-1-IL) -ACETAMIDE WITH NOOTROPIC ACTIVITY
TR200703183A2 (tr) Bir eğitim yöntemi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties